دورية أكاديمية
Recognizing the psychological impact of a glioma diagnosis on mental and behavioral health: a systematic review of what neurosurgeons need to know.
| العنوان: | Recognizing the psychological impact of a glioma diagnosis on mental and behavioral health: a systematic review of what neurosurgeons need to know. |
|---|---|
| المؤلفون: | Young JS; 1Department of Neurological Surgery, University of California, San Francisco, California., Al-Adli N; 1Department of Neurological Surgery, University of California, San Francisco, California.; 2School of Medicine, Texas Christian University, Fort Worth, Texas., Sibih YE; 1Department of Neurological Surgery, University of California, San Francisco, California., Scotford KL; 1Department of Neurological Surgery, University of California, San Francisco, California., Casey M; 3School of Medicine, University of California, San Francisco, California; and., James S; 4Department of Psychiatry, Clarity Behavioral Heath Solutions, San Rafael, California., Berger MS; 1Department of Neurological Surgery, University of California, San Francisco, California. |
| المصدر: | Journal of neurosurgery [J Neurosurg] 2022 Nov 04; Vol. 139 (1), pp. 11-19. Date of Electronic Publication: 2022 Nov 04 (Print Publication: 2023). |
| نوع المنشور: | Systematic Review; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Association of Neurological Surgeons Country of Publication: United States NLM ID: 0253357 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1933-0693 (Electronic) Linking ISSN: 00223085 NLM ISO Abbreviation: J Neurosurg Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Charlottesville, VA : American Association of Neurological Surgeons Original Publication: Chicago [etc.] |
| مواضيع طبية MeSH: | Mental Disorders*/etiology , Glioma*/diagnosis , Glioma*/surgery, Humans ; Quality of Life/psychology ; Neurosurgeons ; Mental Health |
| مستخلص: | A cancer diagnosis is life altering and frequently associated with both acute and long-lasting psychosocial and behavioral distress for patients. The impact of a diffuse glioma diagnosis on mental health is an important aspect of the patient experience with their disease. This needs to be understood by neurosurgeons so these concerns can be appropriately addressed in a timely fashion and integrated into the multidisciplinary care of neuro-oncology patients. The relatively grave prognosis associated with diffuse gliomas, the morbidity associated with treatment, and the constant threat of developing a new neurological deficit all can negatively affect a patient's mental ability to cope and ultimately manifest in mental health disorders such as anxiety and depression. The objective of this systematic review was to describe the variety of behavioral health disorders patients may experience following a glioma diagnosis and discuss possible treatment options. The PubMed, Web of Science, Embase, and PsycINFO databases were searched through July 1, 2022, using broad search terms, which resulted in 5028 studies that were uploaded to Covidence systematic review software. Duplicates, non-English-language studies, and studies with irrelevant outcomes or incorrect design were removed (n = 3167). A total of 92 articles reporting behavioral health outcomes in brain tumor patients were categorized and extracted for associations with overall mental health, anxiety, depression, distress, stress, pharmacology, interventions, and mental health in caregivers. The authors identified numerous studies reporting the prevalence of mental health disorders and their negative influence in this population. However, there is a paucity of literature on therapeutic options for patients. Given the strong correlation between patient quality of life and mental well-being, there is a considerable need for early recognition and treatment of these behavioral health disorders to optimize everyday functioning for patients. |
| References: | J Neurosurg. 2005 Nov;103(5):841-7. (PMID: 16304988) Neurosurg Rev. 2021 Dec;44(6):3047-3057. (PMID: 33608828) Neuro Oncol. 2008 Apr;10(2):171-81. (PMID: 18314416) Lung Cancer. 2016 Oct;100:110-113. (PMID: 27597289) Neurooncol Pract. 2020 Apr 10;7(5):498-506. (PMID: 33014390) Clin Neurol Neurosurg. 2007 Sep;109(7):634-8. (PMID: 17601658) Front Psychol. 2021 May 28;12:642345. (PMID: 34122231) J Cancer Surviv. 2008 Dec;2(4):269-74. (PMID: 18958627) Medicine (Baltimore). 2021 Feb 5;100(5):e23056. (PMID: 33592815) Patient Educ Couns. 2008 May;71(2):251-8. (PMID: 18329220) J Neurooncol. 2022 May;157(3):475-485. (PMID: 35397081) Cochrane Database Syst Rev. 2020 Jul 17;7:CD006932. (PMID: 32678464) Clin Psychol (New York). 2008;15(3):243-253. (PMID: 21369344) Cancers (Basel). 2022 Mar 08;14(6):. (PMID: 35326529) Stress Health. 2012 Dec;28(5):416-25. (PMID: 23129561) World Neurosurg. 2020 Oct;142:e458-e473. (PMID: 32682998) Front Oncol. 2021 May 20;11:662039. (PMID: 34094955) J Neurooncol. 2021 May;153(1):89-98. (PMID: 33822293) Springerplus. 2016 Jun 21;5(1):823. (PMID: 27390663) Br J Cancer. 2021 Apr;124(8):1341-1343. (PMID: 33623077) J Neurooncol. 2018 Dec;140(3):739-748. (PMID: 30471051) J Psychiatr Res. 2022 Jul;151:354-364. (PMID: 35537372) J Clin Psychol Med Settings. 2021 Mar;28(1):16-30. (PMID: 31848927) J Cancer Res Ther. 2018 Dec;14(Supplement):S1048-S1051. (PMID: 30539844) J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1278-82. (PMID: 12933936) Psychooncology. 2011 Jun;20(6):623-30. (PMID: 21449043) Brain Behav Immun Health. 2022 Mar 23;21:100449. (PMID: 35368609) Psychooncology. 2018 Aug;27(8):1930-1936. (PMID: 29683227) Neurosurgery. 2004 Feb;54(2):358-66; discussion 366-7. (PMID: 14744282) Psychooncology. 2002 May-Jun;11(3):230-8. (PMID: 12112483) Neurooncol Pract. 2021 Nov 10;9(1):3-17. (PMID: 35087674) Child Care Health Dev. 2011 Mar;37(2):244-51. (PMID: 21083688) Br J Cancer. 2021 Apr;124(8):1379-1387. (PMID: 33623076) Front Neurol. 2013 Jul 22;4:99. (PMID: 23885253) Support Care Cancer. 2006 Dec;14(12):1213-9. (PMID: 16733656) Am J Clin Oncol. 2011 Aug;34(4):385-7. (PMID: 20859197) Acta Neurochir (Wien). 2018 Jun;160(6):1187-1194. (PMID: 29594548) Psychooncology. 2019 Jan;28(1):11-21. (PMID: 30280453) Medicine (Baltimore). 2022 Jul 1;101(26):e29771. (PMID: 35776994) J Neurosurg. 2003 Jun;98(6):1175-81. (PMID: 12816260) Neuro Oncol. 2016 Jan;18(1):119-25. (PMID: 26109686) Front Psychol. 2018 May 22;9:785. (PMID: 29892240) Support Care Cancer. 2007 Dec;15(12):1423-8. (PMID: 17609991) J Neurooncol. 2012 Mar;107(1):175-81. (PMID: 21968946) Front Oncol. 2022 Jan 17;11:795247. (PMID: 35111678) Res Nurs Health. 2006 Apr;29(2):105-20. (PMID: 16532486) Turk Neurosurg. 2019;29(2):289-296. (PMID: 30843598) BMC Cancer. 2021 Mar 8;21(1):248. (PMID: 33685410) Clin Neurol Neurosurg. 2021 Jan;200:106364. (PMID: 33348302) Ther Adv Med Oncol. 2019 Aug 01;11:1758835919866362. (PMID: 31413731) J Natl Cancer Inst. 2011 Jan 5;103(1):61-76. (PMID: 21106962) J Neurosurg. 2008 Feb;108(2):281-6. (PMID: 18240923) Front Psychol. 2021 Aug 16;12:664235. (PMID: 34489787) J Neurooncol. 2002 Mar;57(1):41-9. (PMID: 12125966) Support Care Cancer. 2009 Jul;17(7):793-9. (PMID: 19421789) J Neurol Neurosurg Psychiatry. 2014 Feb;85(2):230-5. (PMID: 24029545) Front Oncol. 2021 Aug 11;11:702017. (PMID: 34458144) Brain Behav Immun Health. 2020 Feb;2:. (PMID: 32190845) Surg Neurol. 2009 Mar;71(3):299-303, discussion 303. (PMID: 18786716) Psychooncology. 2015 May;24(5):540-7. (PMID: 25251838) Cancer Cell. 2016 Nov 14;30(5):683-693. (PMID: 27746144) Front Oncol. 2015 Mar 26;5:71. (PMID: 25859430) Eur J Oncol Nurs. 2019 Oct;42:1-6. (PMID: 31446258) J Neurooncol. 2012 Jun;108(2):319-26. (PMID: 22350433) BMJ Open. 2020 Sep 9;10(9):e032748. (PMID: 32912937) Eur J Oncol Nurs. 2013 Feb;17(1):107-17. (PMID: 22658206) J Natl Compr Canc Netw. 2020 Sep;18(9):1222-1229. (PMID: 32886907) J Neurosci Nurs. 2010 Apr;42(2):104-8. (PMID: 20422796) Neurosurgery. 2005 Jun;56(6):1234-41; discussion 1241-2. (PMID: 15918939) Am J Phys Med Rehabil. 2001 May;80(5):346-50. (PMID: 11327556) J Neurooncol. 2013 Jul;113(3):505-12. (PMID: 23677748) J Clin Oncol. 2011 Nov 10;29(32):4307-12. (PMID: 21990406) Support Care Cancer. 2021 Aug;29(8):4555-4563. (PMID: 33479794) J Neurooncol. 2022 Feb;156(3):499-507. (PMID: 35064450) World Neurosurg. 2019 Sep;129:e381-e386. (PMID: 31136840) J Neurosurg Anesthesiol. 2009 Apr;21(2):127-30. (PMID: 19295391) J Neurol. 2017 May;264(5):921-927. (PMID: 28315958) Support Care Cancer. 2022 Jul;30(7):5811-5820. (PMID: 35353218) J Neurooncol. 2019 Apr;142(2):385-392. (PMID: 30706175) Neurology. 2011 Aug 9;77(6):532-9. (PMID: 21795655) Ann Palliat Med. 2021 Jan;10(1):875-892. (PMID: 32692231) Neurooncol Pract. 2019 Jul;6(4):311-320. (PMID: 31386042) Neuropsychiatr Dis Treat. 2015 Jun 10;11:1413-20. (PMID: 26089669) Psychosomatics. 2020 May - Jun;61(3):209-219. (PMID: 32139084) BMC Psychol. 2020 Sep 10;8(1):96. (PMID: 32912313) Clin Neurol Neurosurg. 2018 Sep;172:8-19. (PMID: 29957299) JAMA. 2005 Feb 2;293(5):557-64. (PMID: 15687310) J Neurooncol. 2017 Sep;134(2):363-369. (PMID: 28669010) Ir J Med Sci. 2021 Aug;190(3):1155-1164. (PMID: 33140294) |
| معلومات مُعتمدة: | T32 CA151022 United States CA NCI NIH HHS |
| فهرسة مساهمة: | Keywords: glioma; mental health; neurobehavioral; oncology; primary brain tumor; psychosocial; quality of life |
| تواريخ الأحداث: | Date Created: 20221105 Date Completed: 20230704 Latest Revision: 20230811 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC10413205 |
| DOI: | 10.3171/2022.9.JNS221139 |
| PMID: | 36334288 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1933-0693 |
|---|---|
| DOI: | 10.3171/2022.9.JNS221139 |